Loading cancer entity…
Loading cancer entity…
Clinical trials
62 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00790400 | Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)(EXIST-2) | completed | Phase 3 | 118 | Novartis PharmaceuticalsINDUSTRY | 11 | Feb 17, 2017 | clinicaltrials |
| NCT02334930 | Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors(PEC-Hem) | completed | — | 13 | University Hospital, BordeauxOTHER |
| 1 |
| Aug 22, 2016 |
| clinicaltrials |
| NCT00005486 | Lymphangioleiomyomatosis (LAM) Registry | completed | — | — | National Heart, Lung, and Blood Institute (NHLBI)NIH | 0 | Feb 18, 2016 | clinicaltrials |
| NCT02009241 | Pulmonary Rehabilitation in Lymphangioleiomyomatosis | completed | N/A | 40 | University of Sao Paulo General HospitalOTHER | 1 | Dec 11, 2015 | clinicaltrials |
| NCT00989742 | Doxycycline In Lymphangioleiomyomatosis (LAM) | completed | Phase 4 | 24 | University of NottinghamOTHER | 1 | Dec 2, 2015 | clinicaltrials |
| NCT00457964 | RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM | completed | Phase 1 / Phase 2 | 36 | Children's Hospital Medical Center, CincinnatiOTHER | 1 | Sep 25, 2013 | clinicaltrials |
| NCT01690871 | A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa | withdrawn | Phase 2 | 0 | Novartis PharmaceuticalsINDUSTRY | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01217125 | Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis | completed | Phase 4 | 18 | Fundacio PuigvertOTHER | 0 | Mar 8, 2012 | clinicaltrials |
| NCT00960895 | Pulmonary Hypertension in Lymphangioleiomyomatosis(LAM-PH) | completed | — | 20 | Groupe d'Etudes et de Recherche sur les Maladies Orphelines PulmonairesOTHER | 1 | Oct 27, 2011 | clinicaltrials |
| NCT00005906 | Treatment With Octreotide in Patients With Lymphangioleiomyomatosis | completed | Phase 2 | 4 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Apr 30, 2010 | clinicaltrials |
| NCT00490789 | Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM(TESSTAL) | unknown | Phase 2 | 14 | Cardiff UniversityOTHER | 1 | Apr 30, 2008 | clinicaltrials |
| NCT00457808 | Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM | completed | Phase 2 | 25 | Children's Hospital Medical Center, CincinnatiOTHER | 1 | Apr 9, 2007 | clinicaltrials |
Data updated 22 days agoSource updated Feb 17, 2017source: clinicaltrials